Overall rank by patents
#32,078
Across all tracked assignees
USPTO PatentsView assignee record - 8 granted patents across 2 technology areas, active 2021–2025. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: E21B (EARTH OR ROCK DRILLING; OBTAINING OIL, GAS, WATER, SOLUBLE OR MELTABLE MATERIALS OR A SLURRY OF MINERALS FROM WELLS).
The verdict
Imperative holds 8 US patents across 2 technology areas, rank #32,078 of 50,000 tracked assignees.
Imperative Chemical Partners Inc. has been granted 8 US utility patents between 2021 and 2025, placing Imperative Chemical Partners Inc. at rank #32,078 across all assignees tracked by PlainPatent. This portfolio spans 2 distinct Cooperative Patent Classification (CPC) subclasses, averaging 1.0 claims per patent with primary concentration in E21B (EARTH OR ROCK DRILLING; OBTAINING OIL, GAS, WATER, SOLUBLE OR MELTABLE MATERIALS OR A SLURRY OF MINERALS FROM WELLS). As a US Corporation, Imperative Chemical Partners Inc. is one of the more focused assignees in the PatentsView dataset. By volume, Imperative sits between Imerys Filtration Minerals, Inc. (8 patents, rank #32,074) and Imprenditore Pty Ltd. (8 patents, rank #32,082) - the closest US assignees by grant volume. The composite Innovation Score of 19.9/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.
Filing cadence tells the strategic story. Historical data spans 2021 through 2025, with 8 total grants over that period. Velocity comparisons require five years of historical filings to calibrate. The US Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.
Claim depth and technology breadth together indicate competitive posture. Imperative Chemical Partners Inc.'s 1.0 average claims per patent suggests focused, narrowly drawn claims typical of single-invention filings, while specialization in 2 subclasses reflects a tightly scoped invention area. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Imperative Chemical Partners Inc. against peers pursuing similar technology classes.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
Imerys Filtration Minerals, Inc.
8 patents
Immatics US, INC.
8 patents
ImmuNext, Inc.
8 patents
Immunomic Therapeutics, Inc.
8 patents
Imperial Pools, Inc.
8 patents
Implant Sciences Corporation
8 patents
Implicit, LLC
8 patents
Imprenditore Pty Ltd.
8 patents
Imperative Chemical Partners Inc.
8 patents
What this shows Imperative holds 8 patents at rank #32,078, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
By rank, the assignees closest to #32,078 in granted patent volume.
Other assignees with the most granted patents in Imperative's primary technology class.
Imperative's Innovation Score vs. every tracked assignee
Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)
20 Top 94% higher than 6% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2021–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2021 | 3 | 37.5% |
| 2023 | 1 | 12.5% |
| 2024 | 2 | 25.0% |
| 2025 | 2 | 25.0% |
Top 2 of 2 technology areas
Overall rank by patents
#32,078
Across all tracked assignees
19.9 out of 100
How to use this portfolio
Imperative's 8 grants land it in the top 94% by Innovation Score, but volume alone doesn't tell you where the strength sits.
Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.